antibiotic resistance MALDI-TOF Mass Spec Approach Can Predict Antimicrobial Resistance in Clinical Samples A Swiss team said the mass spectrometry- and machine learning-based approach could help guide clinical treatment choices. CSIRO Develops Software to Detect Foreign DNA Without Reference Genomes Premium The INSIDER algorithm, which grew out of SARS-CoV-2 variant research, looks for shifts in k-mer signatures to streamline the search for novel genomic patterns. Torus Biosystems Completes $25M Series A Financing Round The funding round was led by Northpond Ventures, and Northpond's director Adam Wieschhaus will join Torus' board of directors. T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy Premium The company is working to transition its instruments sold in the US from COVID-19 testing to sepsis testing and increase its installed base. After Winning XPrize, ChromaCode Sets Sights on SARS-CoV-2 Testing Expansion Premium The firm also recently validated its instrument-agnostic technology's ability to detect up to 20 targets per qPCR well using high-definition PCR. Mar 18, 2021 SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey Mar 15, 2021 Roche to Acquire GenMark Diagnostics for $1.8B Mar 1, 2021 Host DNA Methylation Signatures May Predict Likelihood of Persistent, Resolving MRSA Infections Feb 24, 2021 LexaGene Open-Access Syndromic Panel Platform Lets Labs Customize Targets, Including SARS-CoV-2 Premium Feb 18, 2021 E. Coli Metabolic Gene Mutations Implicated in Antibiotic Resistance Jan 13, 2021 OpGen Preliminary Q4 Revenue Climbs 63 Percent Nov 11, 2020 OpGen Posts 70 Percent Increase in Q3 Revenues Amid Shuffling of Portfolio Oct 23, 2020 ICBiome Bets on Whole-Genome Sequencing Analysis to Control MRSA, COVID-19 Outbreaks Premium Oct 14, 2020 OpGen Provides Additional Info to FDA on Antimicrobial Resistance Gene Panel Oct 8, 2020 Genomic Data Helps Explain Yaws Re-emergence, Antibiotic Resistance in Papua New Guinea Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Sep 30, 2020 Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test Sep 24, 2020 Antibiotic Resistance Spread in Europe Informed by Bacterial Plasmid Sequencing Sep 8, 2020 Scope Fluidics Secures €10M Loan From European Investment Bank Aug 5, 2020 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition Jul 28, 2020 Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease Premium Jun 16, 2020 Roche, SpeeDx Partner to Expand Access to Antibiotic Resistance Tests Jun 8, 2020 Metagenomic Survey of Hospital Sites Uncovers Two Ecological Niches Contributing to Infections Apr 14, 2020 OpGen Q1 Preliminary Revenues Down 38 Percent Mar 27, 2020 New Method for Detecting Point Mutations Could Significantly Impact Low-Cost Diagnostics Premium Load More Breaking News NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.